Company Name
Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical Co., Ltd.
Year of Establishment
-2001
Enterprise Size
250 to 299
Annual Turnover(USD)
choose not to disclose
Company Introduction
Focusing on the research and development of pharmaceuticals for immunity adjustment, anti-inflammatory, analgesic, antibiotics, and anticancer, Tianji has one GMP workshop for peptide APIs production, and three GMP workshops for injections and freeze-dried powder injections.
So far, the platform for new drug development, the platform for peptides custom synthesis and manufacturing and the platform for protected amino acids synthesis have been established. Meanwhile, cooperating with several universities, the R&D center for finished dosages is one of the key centers in Suzhou.
Main Competitive Advantages
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Contract Manufacturing,Buyers Specifications Accepted,Small Orders Accepted,Quality Service,
Other Competitive Advantages
Excellent experience on the peptides R&D and production.